Tags |
|
|
Links |
|
|
Actual - Does Your Current Backup System Meet Federal Regulations?
The Health Insurance Portability and Accountability Act of 1996 (HIPAA), Public Law 104-191, mandates that all covered entities fulfill certain requir
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ements for data backup, storage, and recovery; the Sarbanes-Oxley Act (SOX) holds many publicly held companies and all Registered Public Accounting Fi
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
rms to a rigorous set of standards. These rules set guidelines for how data should be stored, accessed, and retrieved.
In response to an explosion of
In response to an explosion of
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
major corporate benefits and accounting scandals in recent years, Congress passed two laws regulating the storage and reporting of internal data.
Th
Th
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
e first impact was felt in corporate America by the passage of the Health Insurance Portability and Accountability Act (HIPAA) in 1996. The Administr
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ative Simplification (AS) provisions of HIPAA mandated national standards for electronic health care transactions and identifiers for providers, healt
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
h insurance plans, and employers.
Under HIPAA, an IT audit most often is performed in conjunction with a financial statement audit or an internal aud
Under HIPAA, an IT audit most often is performed in conjunction with a financial statement audit or an internal aud
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
it. Evidence is collected and evaluated concerning an organization's information systems, practices, and operations to determine whether those systems
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
record and maintain accurate, reliable data.
An IT audit doesn't focus on internal controls in the way a financial audit does. Rather, it seeks to
An IT audit doesn't focus on internal controls in the way a financial audit does. Rather, it seeks to
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
determine risks relevant to information assets, and to assess whatever controls are in place to eliminate or reduce those risks. The focus of an IT au
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
dit is on evaluating a system's availability, confidentiality and integrity.
The Sarbanes-Oxley Act of 2002 created (among other oversight regulation
The Sarbanes-Oxley Act of 2002 created (among other oversight regulation
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
s) the Public Company Accounting Oversight Board (PCAOB), which addresses the role IT plays in a company's internal controls. The PCAOB's "Auditing S
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
tandard 2" states: "The nature and characteristics of a company's use of information technology in its information system affect the company's interna
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
l control over financial reporting," and its provisions are targeted toward seeing that those controls and reporting are legitimate and accurate.
Un
Un
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
der this law, auditors audit key and general controls, with "key" controls being those that are key to ensuring that numbers shown on the company's ba
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
lance sheet are authentic. (For instance, there might be a trigger on a database table to ensure that adding any entry into the accounts receivable ta
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ble automatically creates an entry into the general ledger.) The person held accountable for seeing that these regulations are met is the company's C
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
hief Information Officer (CIO).
Given the breadth and complexity of current federal law governing storage and maintenance of IT data, prudent busines
Given the breadth and complexity of current federal law governing storage and maintenance of IT data, prudent busines
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
s owners will take whatever steps necessary to assure their IT systems and controls meet or exceed regulations. Taking the time today to ascertain th
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
at your online offsite backup system complies with federal regulations will save you countless intrusive and costly auditing headaches, down the road.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.actual.org.ua/article/171354/actual-Does-Your-Current-Backup-System-Meet-Federal-Regulations.html">Does Your Current Backup System Meet Federal Regulations?</a>
BB link (for phorums):
[url=http://www.actual.org.ua/article/171354/actual-Does-Your-Current-Backup-System-Meet-Federal-Regulations.html]Does Your Current Backup System Meet Federal Regulations?[/url]
Related Articles:
Advertising and Public Relations India
Successful Fundraising Donation Letters Use Before-And-After Samples, Examples
The Difference Between Secured Loans and Unsecured Loans
Bookmark it:
|